Pulmonary hemorrhage: Clinical course and outcomes among very low- birth-weight infants

Archives of Pediatrics and Adolescent Medicine

Volumn 153, Issue 7, 1999, Pages 715-721

  Tomaszewska, Maria ^a   Stork, Eileen ^a   Minich, Nori Mercuri ^a   Friedman, Harriet ^a   Berlin, Sheila ^a   Hack, Maureen ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; INFANT; LEUKOMALACIA; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MORTALITY; NECROTIZING ENTEROCOLITIS; NERVOUS SYSTEM DEVELOPMENT; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RISK FACTOR; SEIZURE; SURVIVAL RATE; VERY LOW BIRTH WEIGHT;

EID: 0033050188     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.153.7.715     Document Type: Article

References (28)

1. Esterly JR, Oppenheimer EH. Massive pulmonary hemorrhage in the newborn, I: pathologic consideration. J Pediatr. 1966;69:3-11.
2. Rowe S, Avery ME. Massive pulmonary hemorrhage in the newborn, II: clinical consideration. J Pediatr. 1966;69:12-20.
3. Butler NR, Alberman ED, eds. Perinatal Problems. London, England: E&S Livingstone Ltd; 1969.
4. Fedrick J, Butler NR. Certain causes of neonatal death. Biol Neonate. 1971;18: 243-262.
5. Cole VA, Normand ICS, Reynolds EOR, Rivers RPA. Pathogenesis of hemorrhagic pulmonary edema and massive pulmonary hemorrhage in the newborn. Pediatrics. 1973;51:175-187.
6. Stevenson D, Walther F, Long W, et al. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. J Pediatr. 1992;120:S3-S12.
7. Zola EM, Overbach AM, Gunkel JH, et al. Treatment investigational new drug experience with Survanta (beractant). Pediatrics. 1993;91:546-551.
8. Raju T, Langenberg P. Pulmonary hemorrhage and exogenous surfactant therapy: a meta-analysis. J Pediatr. 1993;123:603-610.
9. Horbar JD, Wright LL, Soll RF, et al. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. Pediatrics. 1993;123:757-766.
10. Valencia G, Allen L, Claude S, Cobham A, Glass A, Anderson V. Pulmonary hemorrhage: a severe complication in preterm infants administered surfactant replacement therapy [abstract]. Pediatr Res. 1992;31:226A.
11. Bhandari V, Gasnon C, Hussain N, Rosenkrantz T. Pulmonary hemorrhage in neonates [abstract]. Pediatr Res. 1995;39:196A.
12. Geraldo V, Agrawal V, Wilks A. Does pulmonary hemorrhage contribute to excess mortality in ELBW neonates receiving surfactant therapy [abstract]? Pediatr Res. 1996;39:209A.
13. Braun K, Nielsen HC. Antecedents of neonatal pulmonary hemorrhage in the surfactant era [abstract]. Pediatr Res. 1996;39:259A.
14. Garland J, Buck R, Weinberg M. Pulmonary hemorrhage risk in infants with clinically diagnosed patent ductus arteriosus: a retrospective cohort study. Pediatrics. 1994;94:719-723.
15. Pandit P, O'Brien K, Dunn M, Asztalos E, Colucci E. Outcome following pulmonary hemorrhage (PH) in very low birth weight neonates treated with surfactant [abstract]. Pediatr Res. 1997;41:208A.
16. Roberton NRC. Pulmonary oedema/pulmonary haemorrhage. In: Greenough A, Milner AD, Roberton NRC, eds. Neonatal Respiratory Disorders. London, England: Arnold; 1996:375-385.
17. Gonzales A, Hummler H, Sosenko IRS, Chandar J, Goldberg RN, Bancalari E. Surfactant administration, patent ductus arteriosus, and pulmonary hemorrhage in premature infants <1000 g [abstract]. Pediatr Res. 1994;35:227A.
18. Usher R, McLean F, Intrauterine growth of live-born caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr. 1969;72:901-910.
19. Shennan AT, Dunn MS, Ohlsson A, Lenox K. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988;82:527-532.
20. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhages: a study of infants with birthweights less than 1500 g. J Pediatr. 1978;92:529-534.
21. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based on clinical staging. Ann Surg. 1978;187:1-7.
22. Amiel-Tison C, Stewart AL. Follow-up studies in the first five years of life: a pervasive assessment of neurologic function. Arch Dis Child. 1989;64:496-502.
23. Bayley N. Bayley Scales of Infant Development. New York, NY: The Psychological Corp; 1969.
24. Bayley N. Bayley Scales of Infant Development. 2nd ed. San Antonio, Tex: The Psychological Corp; 1993.
25. Covert RE, Domanico RS, Barman N, et al. Prophylactic indomethacin: effect on pulmonary hemorrhage and bronchopulmonary dysplasia in surfactant-treated infants <1250 g [abstract]. Pediatr Res. 1996;39:203A.
26. West J, Mathieu-Costello O. Stress failure of pulmonary capillaries: role in lung and heart disease. Lancet. 1992;340:762-767.
27. Kääpä P, Seppänen M, Kero P, Saraste M. Pulmonary hemodynamics after synthetic surfactant replacement in neonatal respiratory distress syndrome. J Pediatr. 1993;123:115-119.
28. Bhutani VK, Abbasi S, Long WA, Gerdes JS. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant. J Pediatr. 1992;120:S18-S24.